SHSE:688193 (China)
Â
Class A
Â¥
42.05
+1.67 (+4.14%)
Jul 23
Business Description
Shanghai Rendu Biotechnology Co Ltd
ISIN : CNE1000059K5
Share Class Description:
SHSE:688193: Class ATotal Employee Number:
239Compare
Compare
Traded in other countries / regions
688193.China Index Membership
SSE Composite Index IPO Date
2022-03-30Description
Shanghai Rendu Biotechnology Co Ltd provides solutions for accurate diagnosis, effective prevention and control, as well as personalized diagnosis and treatment of pathogens in the areas of reproduction, respiration, digestion, blood, food, and environmental safety.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 157.1 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.33 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 17.65 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.3 | |||||
3-Year EBITDA Growth Rate | -14.1 | |||||
3-Year Book Growth Rate | -1.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.12 | |||||
9-Day RSI | 28.63 | |||||
14-Day RSI | 31.17 | |||||
3-1 Month Momentum % | -3.48 | |||||
6-1 Month Momentum % | 5.88 | |||||
12-1 Month Momentum % | 8.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 14.97 | |||||
Quick Ratio | 14.64 | |||||
Cash Ratio | 13.25 | |||||
Days Inventory | 229.86 | |||||
Days Sales Outstanding | 105.35 | |||||
Days Payable | 28.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.85 | |||||
Dividend Payout Ratio | 1.66 | |||||
Forward Dividend Yield % | 3.1 | |||||
5-Year Yield-on-Cost % | 2.63 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 2.58 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 77.91 | |||||
Operating Margin % | -5.51 | |||||
Net Margin % | 8.49 | |||||
EBITDA Margin % | 9.4 | |||||
FCF Margin % | 5.3 | |||||
OCF Margin % | 9.26 | |||||
ROE % | 1.52 | |||||
ROA % | 1.4 | |||||
ROIC % | -5.57 | |||||
3-Year ROIIC % | 91.42 | |||||
ROC (Joel Greenblatt) % | 13.36 | |||||
ROCE % | 1.66 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 120.14 | |||||
PE Ratio without NRI | 278.48 | |||||
PS Ratio | 9.54 | |||||
PB Ratio | 1.83 | |||||
Price-to-Tangible-Book | 1.83 | |||||
Price-to-Free-Cash-Flow | 184.43 | |||||
Price-to-Operating-Cash-Flow | 105.9 | |||||
EV-to-EBIT | 62.38 | |||||
EV-to-EBITDA | 62.38 | |||||
EV-to-Revenue | 5.86 | |||||
EV-to-FCF | 110.72 | |||||
Price-to-GF-Value | 1.2 | |||||
Price-to-Graham-Number | 4.77 | |||||
| Price-to-Net-Current-Asset-Value | 2.04 | |||||
| Price-to-Net-Cash | 2.33 | |||||
Earnings Yield (Greenblatt) % | 1.6 | |||||
FCF Yield % | 0.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Rendu Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 163.337 | ||
| EPS (TTM) (Â¥) | 0.35 | ||
| Beta | 1.1943 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 45.14 | ||
| 14-Day RSI | 31.17 | ||
| 14-Day ATR (Â¥) | 2.654242 | ||
| 20-Day SMA (Â¥) | 48.4845 | ||
| 12-1 Month Momentum % | 8.68 | ||
| 52-Week Range (Â¥) | 40 - 63.56 | ||
| Shares Outstanding (Mil) | 40.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Rendu Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Rendu Biotechnology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 1.000000 Cash Dividend | 2026-06-10 | 52.93 (+7.60%) | ||
| CNY 0.150000 Cash Dividend | 2025-11-26 | 47.44 (+2.26%) | ||
| CNY 0.100000 Cash Dividend | 2025-06-27 | 40.41 (-0.74%) | ||
| CNY 0.100000 Cash Dividend | 2024-10-30 | 35.80 (-5.74%) |
Show
Entries
Shanghai Rendu Biotechnology Co Ltd Frequently Asked Questions
What is Shanghai Rendu Biotechnology Co Ltd(SHSE:688193)'s stock price today?
The current price of SHSE:688193 is ¥42.05. The 52 week high of SHSE:688193 is ¥63.56 and 52 week low is ¥40.00.
When is next earnings date of Shanghai Rendu Biotechnology Co Ltd(SHSE:688193)?
The next earnings date of Shanghai Rendu Biotechnology Co Ltd(SHSE:688193) is .
Does Shanghai Rendu Biotechnology Co Ltd(SHSE:688193) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Rendu Biotechnology Co Ltd(SHSE:688193) is 2.85% (As of Today), Highest Dividend Payout Ratio of Shanghai Rendu Biotechnology Co Ltd(SHSE:688193) was 1.66. The lowest was 0.6. And the median was 0.78. The  Forward Dividend Yield % of Shanghai Rendu Biotechnology Co Ltd(SHSE:688193) is 3.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai Rendu Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers